Easy Access and Express Report Delivery Service
GMP Viral Vector Manufacturing Market, Global Outlook and Forecast 2023-2029
Report ID
43542
Publisher
Market Monitor Global
Published Date
07-Dec
Delivery Format
PDF
No of Report Page
143
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the GMP Viral Vector Manufacturing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global GMP Viral Vector Manufacturing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of GMP Viral Vector Manufacturing, challenges faced by the industry, and potential opportunities for market players. The global GMP Viral Vector Manufacturing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The GMP Viral Vector Manufacturing market presents opportunities for various stakeholders, including Clinical Research, Commercial Production. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in GMP Viral Vector Manufacturing market. Additionally, the growing consumer demand present avenues for market expansion. The global GMP Viral Vector Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. Key Features: The research report on the GMP Viral Vector Manufacturing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the GMP Viral Vector Manufacturing market. Market Overview: The report provides a comprehensive overview of the GMP Viral Vector Manufacturing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Adenovirus Vector Manufacturing, AAV Vector Manufacturing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the GMP Viral Vector Manufacturing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the GMP Viral Vector Manufacturing market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the GMP Viral Vector Manufacturing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the GMP Viral Vector Manufacturing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the GMP Viral Vector Manufacturing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the GMP Viral Vector Manufacturing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for GMP Viral Vector Manufacturing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the GMP Viral Vector Manufacturing market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation GMP Viral Vector Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type Adenovirus Vector Manufacturing AAV Vector Manufacturing Retroviral Vector Manufacturing Lentiviral Vector Manufacturing Others Market segment by Application Clinical Research Commercial Production Others Global GMP Viral Vector Manufacturing Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Advanced BioScience Laboratories Biovian Lonza Takara Bio Genezen Halix Merck Batavia Biosciences Exothera WuXi Biologics Vectorbuilder Abace-Biology Genscript Cytiva Obiosh Pregene Outline of Major Chapters: Chapter 1: Introduces the definition of GMP Viral Vector Manufacturing, market overview. Chapter 2: Global GMP Viral Vector Manufacturing market size in revenue and volume. Chapter 3: Detailed analysis of GMP Viral Vector Manufacturing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of GMP Viral Vector Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global GMP Viral Vector Manufacturing capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 GMP Viral Vector Manufacturing Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global GMP Viral Vector Manufacturing Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global GMP Viral Vector Manufacturing Overall Market Size 2.1 Global GMP Viral Vector Manufacturing Market Size: 2022 VS 2029 2.2 Global GMP Viral Vector Manufacturing Revenue, Prospects & Forecasts: 2018-2029 2.3 Global GMP Viral Vector Manufacturing Sales: 2018-2029 3 Company Landscape 3.1 Top GMP Viral Vector Manufacturing Players in Global Market 3.2 Top Global GMP Viral Vector Manufacturing Companies Ranked by Revenue 3.3 Global GMP Viral Vector Manufacturing Revenue by Companies 3.4 Global GMP Viral Vector Manufacturing Sales by Companies 3.5 Global GMP Viral Vector Manufacturing Price by Manufacturer (2018-2023) 3.6 Top 3 and Top 5 GMP Viral Vector Manufacturing Companies in Global Market, by Revenue in 2022 3.7 Global Manufacturers GMP Viral Vector Manufacturing Product Type 3.8 Tier 1, Tier 2 and Tier 3 GMP Viral Vector Manufacturing Players in Global Market 3.8.1 List of Global Tier 1 GMP Viral Vector Manufacturing Companies 3.8.2 List of Global Tier 2 and Tier 3 GMP Viral Vector Manufacturing Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global GMP Viral Vector Manufacturing Market Size Markets, 2022 & 2029 4.1.2 Adenovirus Vector Manufacturing 4.1.3 AAV Vector Manufacturing 4.1.4 Retroviral Vector Manufacturing 4.1.5 Lentiviral Vector Manufacturing 4.1.6 Others 4.2 By Type - Global GMP Viral Vector Manufacturing Revenue & Forecasts 4.2.1 By Type - Global GMP Viral Vector Manufacturing Revenue, 2018-2023 4.2.2 By Type - Global GMP Viral Vector Manufacturing Revenue, 2024-2029 4.2.3 By Type - Global GMP Viral Vector Manufacturing Revenue Market Share, 2018-2029 4.3 By Type - Global GMP Viral Vector Manufacturing Sales & Forecasts 4.3.1 By Type - Global GMP Viral Vector Manufacturing Sales, 2018-2023 4.3.2 By Type - Global GMP Viral Vector Manufacturing Sales, 2024-2029 4.3.3 By Type - Global GMP Viral Vector Manufacturing Sales Market Share, 2018-2029 4.4 By Type - Global GMP Viral Vector Manufacturing Price (Manufacturers Selling Prices), 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global GMP Viral Vector Manufacturing Market Size, 2022 & 2029 5.1.2 Clinical Research 5.1.3 Commercial Production 5.1.4 Others 5.2 By Application - Global GMP Viral Vector Manufacturing Revenue & Forecasts 5.2.1 By Application - Global GMP Viral Vector Manufacturing Revenue, 2018-2023 5.2.2 By Application - Global GMP Viral Vector Manufacturing Revenue, 2024-2029 5.2.3 By Application - Global GMP Viral Vector Manufacturing Revenue Market Share, 2018-2029 5.3 By Application - Global GMP Viral Vector Manufacturing Sales & Forecasts 5.3.1 By Application - Global GMP Viral Vector Manufacturing Sales, 2018-2023 5.3.2 By Application - Global GMP Viral Vector Manufacturing Sales, 2024-2029 5.3.3 By Application - Global GMP Viral Vector Manufacturing Sales Market Share, 2018-2029 5.4 By Application - Global GMP Viral Vector Manufacturing Price (Manufacturers Selling Prices), 2018-2029 6 Sights by Region 6.1 By Region - Global GMP Viral Vector Manufacturing Market Size, 2022 & 2029 6.2 By Region - Global GMP Viral Vector Manufacturing Revenue & Forecasts 6.2.1 By Region - Global GMP Viral Vector Manufacturing Revenue, 2018-2023 6.2.2 By Region - Global GMP Viral Vector Manufacturing Revenue, 2024-2029 6.2.3 By Region - Global GMP Viral Vector Manufacturing Revenue Market Share, 2018-2029 6.3 By Region - Global GMP Viral Vector Manufacturing Sales & Forecasts 6.3.1 By Region - Global GMP Viral Vector Manufacturing Sales, 2018-2023 6.3.2 By Region - Global GMP Viral Vector Manufacturing Sales, 2024-2029 6.3.3 By Region - Global GMP Viral Vector Manufacturing Sales Market Share, 2018-2029 6.4 North America 6.4.1 By Country - North America GMP Viral Vector Manufacturing Revenue, 2018-2029 6.4.2 By Country - North America GMP Viral Vector Manufacturing Sales, 2018-2029 6.4.3 US GMP Viral Vector Manufacturing Market Size, 2018-2029 6.4.4 Canada GMP Viral Vector Manufacturing Market Size, 2018-2029 6.4.5 Mexico GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5 Europe 6.5.1 By Country - Europe GMP Viral Vector Manufacturing Revenue, 2018-2029 6.5.2 By Country - Europe GMP Viral Vector Manufacturing Sales, 2018-2029 6.5.3 Germany GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5.4 France GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5.5 U.K. GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5.6 Italy GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5.7 Russia GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5.8 Nordic Countries GMP Viral Vector Manufacturing Market Size, 2018-2029 6.5.9 Benelux GMP Viral Vector Manufacturing Market Size, 2018-2029 6.6 Asia 6.6.1 By Region - Asia GMP Viral Vector Manufacturing Revenue, 2018-2029 6.6.2 By Region - Asia GMP Viral Vector Manufacturing Sales, 2018-2029 6.6.3 China GMP Viral Vector Manufacturing Market Size, 2018-2029 6.6.4 Japan GMP Viral Vector Manufacturing Market Size, 2018-2029 6.6.5 South Korea GMP Viral Vector Manufacturing Market Size, 2018-2029 6.6.6 Southeast Asia GMP Viral Vector Manufacturing Market Size, 2018-2029 6.6.7 India GMP Viral Vector Manufacturing Market Size, 2018-2029 6.7 South America 6.7.1 By Country - South America GMP Viral Vector Manufacturing Revenue, 2018-2029 6.7.2 By Country - South America GMP Viral Vector Manufacturing Sales, 2018-2029 6.7.3 Brazil GMP Viral Vector Manufacturing Market Size, 2018-2029 6.7.4 Argentina GMP Viral Vector Manufacturing Market Size, 2018-2029 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa GMP Viral Vector Manufacturing Revenue, 2018-2029 6.8.2 By Country - Middle East & Africa GMP Viral Vector Manufacturing Sales, 2018-2029 6.8.3 Turkey GMP Viral Vector Manufacturing Market Size, 2018-2029 6.8.4 Israel GMP Viral Vector Manufacturing Market Size, 2018-2029 6.8.5 Saudi Arabia GMP Viral Vector Manufacturing Market Size, 2018-2029 6.8.6 UAE GMP Viral Vector Manufacturing Market Size, 2018-2029 7 Manufacturers & Brands Profiles 7.1 Advanced BioScience Laboratories 7.1.1 Advanced BioScience Laboratories Company Summary 7.1.2 Advanced BioScience Laboratories Business Overview 7.1.3 Advanced BioScience Laboratories GMP Viral Vector Manufacturing Major Product Offerings 7.1.4 Advanced BioScience Laboratories GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.1.5 Advanced BioScience Laboratories Key News & Latest Developments 7.2 Biovian 7.2.1 Biovian Company Summary 7.2.2 Biovian Business Overview 7.2.3 Biovian GMP Viral Vector Manufacturing Major Product Offerings 7.2.4 Biovian GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.2.5 Biovian Key News & Latest Developments 7.3 Lonza 7.3.1 Lonza Company Summary 7.3.2 Lonza Business Overview 7.3.3 Lonza GMP Viral Vector Manufacturing Major Product Offerings 7.3.4 Lonza GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.3.5 Lonza Key News & Latest Developments 7.4 Takara Bio 7.4.1 Takara Bio Company Summary 7.4.2 Takara Bio Business Overview 7.4.3 Takara Bio GMP Viral Vector Manufacturing Major Product Offerings 7.4.4 Takara Bio GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.4.5 Takara Bio Key News & Latest Developments 7.5 Genezen 7.5.1 Genezen Company Summary 7.5.2 Genezen Business Overview 7.5.3 Genezen GMP Viral Vector Manufacturing Major Product Offerings 7.5.4 Genezen GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.5.5 Genezen Key News & Latest Developments 7.6 Halix 7.6.1 Halix Company Summary 7.6.2 Halix Business Overview 7.6.3 Halix GMP Viral Vector Manufacturing Major Product Offerings 7.6.4 Halix GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.6.5 Halix Key News & Latest Developments 7.7 Merck 7.7.1 Merck Company Summary 7.7.2 Merck Business Overview 7.7.3 Merck GMP Viral Vector Manufacturing Major Product Offerings 7.7.4 Merck GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.7.5 Merck Key News & Latest Developments 7.8 Batavia Biosciences 7.8.1 Batavia Biosciences Company Summary 7.8.2 Batavia Biosciences Business Overview 7.8.3 Batavia Biosciences GMP Viral Vector Manufacturing Major Product Offerings 7.8.4 Batavia Biosciences GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.8.5 Batavia Biosciences Key News & Latest Developments 7.9 Exothera 7.9.1 Exothera Company Summary 7.9.2 Exothera Business Overview 7.9.3 Exothera GMP Viral Vector Manufacturing Major Product Offerings 7.9.4 Exothera GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.9.5 Exothera Key News & Latest Developments 7.10 WuXi Biologics 7.10.1 WuXi Biologics Company Summary 7.10.2 WuXi Biologics Business Overview 7.10.3 WuXi Biologics GMP Viral Vector Manufacturing Major Product Offerings 7.10.4 WuXi Biologics GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.10.5 WuXi Biologics Key News & Latest Developments 7.11 Vectorbuilder 7.11.1 Vectorbuilder Company Summary 7.11.2 Vectorbuilder Business Overview 7.11.3 Vectorbuilder GMP Viral Vector Manufacturing Major Product Offerings 7.11.4 Vectorbuilder GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.11.5 Vectorbuilder Key News & Latest Developments 7.12 Abace-Biology 7.12.1 Abace-Biology Company Summary 7.12.2 Abace-Biology Business Overview 7.12.3 Abace-Biology GMP Viral Vector Manufacturing Major Product Offerings 7.12.4 Abace-Biology GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.12.5 Abace-Biology Key News & Latest Developments 7.13 Genscript 7.13.1 Genscript Company Summary 7.13.2 Genscript Business Overview 7.13.3 Genscript GMP Viral Vector Manufacturing Major Product Offerings 7.13.4 Genscript GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.13.5 Genscript Key News & Latest Developments 7.14 Cytiva 7.14.1 Cytiva Company Summary 7.14.2 Cytiva Business Overview 7.14.3 Cytiva GMP Viral Vector Manufacturing Major Product Offerings 7.14.4 Cytiva GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.14.5 Cytiva Key News & Latest Developments 7.15 Obiosh 7.15.1 Obiosh Company Summary 7.15.2 Obiosh Business Overview 7.15.3 Obiosh GMP Viral Vector Manufacturing Major Product Offerings 7.15.4 Obiosh GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.15.5 Obiosh Key News & Latest Developments 7.16 Pregene 7.16.1 Pregene Company Summary 7.16.2 Pregene Business Overview 7.16.3 Pregene GMP Viral Vector Manufacturing Major Product Offerings 7.16.4 Pregene GMP Viral Vector Manufacturing Sales and Revenue in Global (2018-2023) 7.16.5 Pregene Key News & Latest Developments 8 Global GMP Viral Vector Manufacturing Production Capacity, Analysis 8.1 Global GMP Viral Vector Manufacturing Production Capacity, 2018-2029 8.2 GMP Viral Vector Manufacturing Production Capacity of Key Manufacturers in Global Market 8.3 Global GMP Viral Vector Manufacturing Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 GMP Viral Vector Manufacturing Supply Chain Analysis 10.1 GMP Viral Vector Manufacturing Industry Value Chain 10.2 GMP Viral Vector Manufacturing Upstream Market 10.3 GMP Viral Vector Manufacturing Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 GMP Viral Vector Manufacturing Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
